Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma

This study has been completed.
Sponsor:
Collaborators:
Massachusetts General Hospital
University of Chicago
Information provided by (Responsible Party):
Pasi A. Janne, MD, PhD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00137826
First received: August 29, 2005
Last updated: December 23, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)